Proteomics: Powering Precision Oncology Breakthroughs
The blueprint of a cancer cell—its DNA—is only half the story. For years, precision oncology has leaned heavily on genomic sequencing to guide treatment. However, clinicians have long faced a frustrating reality: two patients with the same genetic mutation can respond to the same drug in entirely different ways. The missing link isn’t in the … Read more